Navigating Digital Health Technology: A Comprehensive Review of USFDA Regulations

Abstract

Digital health technology is revolutionizing the healthcare landscape by leveraging digital and information technologies to enhance healthcare delivery, monitoring and management. This technology encompasses a wide range of tools, including mobile apps, wearable, telemedicine, electronic health records, and AI-driven diagnostics. Digital health technologies may be beneficial but also problematic. Development requires navigating complicated regulatory systems and meeting changing criteria. These technologies, particularly those using AI algorithms, need robust clinical validation to prove their safety and usefulness. Health data is delicate; thus, privacy and security are crucial. Successful adoption requires interoperability with current healthcare systems, seamless user experience, and ethical and legal considerations. To maximize digital health technology's potential, clinical evidence, financial management, and change resistance must be addressed. Addressing these issues requires collaboration between healthcare professionals, technology professionals, regulators, and patients. Digital health technology can empower people, enhance patient outcomes, and transform healthcare by balancing innovation and safety. Despite challenges, digital health technology improves global health, needing continuing innovation, regulatory compliance, and equal access. This review provides a comprehensive analysis of the US Food and Drug Administration (USFDA) regulations governing digital health technologies, including, classification of DHT, mobile health applications, wearables, Cyber security, Regulatory expectations and challenges.